Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer
Clinical trial NCT06973421 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06973421
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-06-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.